Acer Therapeutics Inc. Stock
Equities
ACER
US00444P1084
Biotechnology & Medical Research
Latest transcript on Acer Therapeutics Inc.
Managers | Title | Age | Since |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | Nov. 16 |
Tanya Hayden
COO | Chief Operating Officer | 44 | 21-05-31 |
John M. Klopp
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | Nov. 16 |
Joshua Schafer
BRD | Director/Board Member | 53 | Nov. 16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.22% | 3 M€ | -.--% | - | |
0.22% | 1 M€ | +3.49% | - |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |